HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physicians Group Urges Acceptance Of Non-Validated Animal Test Alternatives

This article was originally published in The Rose Sheet

You may also be interested in...



Industry May Lean On Outside Animal Data If Humane Cosmetics Act Passes

A ban on cosmetic animal testing in the U.S. would challenge companies' ability to ensure product safety as required by the Federal Food, Drug and Cosmetic Act, particularly with respect to safety-assessment components that can't be readily or confidently addressed by alternative methods. Companies facing liability risks may choose to borrow safety data for their ingredients derived via animal testing in other sectors to meet non-cosmetic regulatory requirements, TSG Senior Regulatory Consultant Bob Stewart suggests.

ICCR To Consider Regulatory Harmonization On Allergen Issues

At FDA’s June 2 public meeting to prepare for the eighth iteration of the International Cooperation on Cosmetics Regulation, the agency recapped accomplishments from ICCR-7 and outlined cosmetic regulatory topics to be addressed at ICCR-8. Allergens are up for discussion, as are trace materials.

ICCR Addresses Lead Limit, Endocrine Disruptors At 7th Meeting

Regulators from the US, Canada, Japan and the EU met in Tokyo July 8-10 for the seventh annual meeting of the International Cooperation on Cosmetics Regulation. The group agreed to recommend a 10-ppm limit on lead in cosmetic products.

Related Content

UsernamePublicRestriction

Register

RS019120

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel